Position in ERAS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$52,824,198
+$28,714,705 QoQ
Shares Held
2,883,417
+93.5% QoQ
Ownership
0.824%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 257 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. ERAS ranks #121 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in ERAS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,824,198 | 2,883,417 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $24,109,493 | 1,490,080 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,939,811 | 521,455 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $914,627 | 419,554 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $478,759 | 376,976 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $492,347 | 359,378 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $804,098 | 320,358 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $835,732 | 306,129 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $543,949 | 230,487 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $285,621 | 138,651 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $123,395 | 57,932 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $15,750 | 7,995 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,066 | 2,198 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,453 | 483 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $40,674,521 | 9,437,244 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $142,911,966 | 18,322,047 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $101,812,107 | 18,278,655 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $153,170,411 | 17,810,513 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $202,881,979 | 13,021,950 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $168,529,727 | 7,942,023 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||